| Literature DB >> 6100790 |
T Di Perri, F Laghi Pasini, A L Pasqui, L Ceccatelli, P L Capecchi, A Orrico.
Abstract
Flunarizine, a calcium entry blocker drug, concentration-dependently inhibited FMLP and A23187-induced aggregation, enzyme release and superoxide anion generation from human granulocytes. A23187-dependent granulocyte aggregation was also studied in media devoided of Ca++ or Mg++. Flunarizine (2.4 x 10(-5) M) significantly affected not only Ca++-supported but also Mg++-sustained granulocyte aggregation. The inhibiting effect of the drug was reversed by increasing extracellular level of Ca++ (1.2 mM) or Mg++ (2 mM). In this "in vitro" model, the role of flunarizine as a specific Mg++ entry blocker was suggested.Entities:
Mesh:
Substances:
Year: 1984 PMID: 6100790
Source DB: PubMed Journal: Microcirc Endothelium Lymphatics ISSN: 0740-9451